Temafloxacin, a new fluoroquinolone, alone or in combination with tobramycin, was compared with penicillin, tobramycin, and their combination in the therapy of rabbits with endocarditis cased by Streptococcus a4iacefts GaDt, a new species of nutritionally variant streptococci. Animals were injected intramuscularly for 4 days with temafloxacin (50 mg/kg of body weight twice daily [b.i.d.1) alone or combined with tobramycin (12 mg/k once daily), with procaine penicillin (150,000 U/kg b.i.d.) alone or combined with tobramycin (12 mg/kg once daily), or with tobramycin (12 mg/kg once daily) alone. Another group of animals was treated with a higher dose of temafloxacin (100 mg/kg b.i.d.). Temafloxacin, penicillin, and tobramycin MICs and MBCs were 1 and 2, 0.015 and 1, and 8 and 16 Lg/ml, respectively. Time-kill curves showed that the addition of tobramycin to penicillin or temafloxacin increased the killing rate. In vivo, treatment with temafloxacin (50 and 100 mg/kg b.i.d.) alone reduced the bacterial counts in vegetations (3.9 ± 0.9 and 3.1 ± 0.8 log1o CFU/g ofvegetation) compared with those in the vegetations of control animals (7.5 t 0.9 log1o CFU/g of vegetation). This result was similar to that obtained with penicillin alone (4.5 -0.8 log1, CFU/g of vegetation). The combination of temafloxacin (50 mg/kg) and tobramycin was as effective as penicillin plus tobramycin (2.5 ± 0.3 versus 2.3 ± 0.4 log1o CFU/g of vegetation, respectively). The autoradiogaphic pattern of [14Cjtemafloxacin diffusion into infected cardiac vegetations was studied. Thirty minutes after the end of infusion of 250 uCi of [14Cjtemafloxacin, the [14Cjtemafloxacin was homogeneously distributed throughout the vegetations. These data support further evaluation of quinolones in experimental endocarditis.
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Nutritionally variant streptococci (NVS) include two individual species, Streptococcus defectivus and Streptococcus adjacens (3) , that are responsible for 5% of the cases of human bacterial endocarditis (19) and have a higher rate of complications than endocarditis caused by other viridans group streptococci (4) . As for the other viridans group streptococci, a regimen combining penicillin plus an aminoglycoside is usually recommended for treatment of NVS endocarditis (1) . Because of the high rates of complications and relapses, some investigators recommend 4 weeks of combination therapy for NVS endocarditis (lOa). Vancomycin is usually considered the only safe and effective alternative therapy in the case of intolerance to 3-lactams (2) .
However, vancomycin used in combination with an aminoglycoside can enhance the toxicity of the latter compound, especially if long-term therapy is needed (23) . Temafloxacin is a new fluoroquinolone with a broad spectrum of activity. In vitro, temafloxacin was reported to be two-to eightfold more potent than ciprofloxacin or ofloxacin against various strains of viridans group streptococci, with MICs comparable to those of ceftriaxone (7a) , and thus deserves to be evaluated as a potential alternative to the treatment of endocarditis when penicillin cannot be used. Although temafloxacin's concentrations have been measured in fibrin clots (22a) , the pattern of diffusion of temafloxacin into fibrin vegetations is not known. The aims of this study were to * Corresponding author.
evaluate, in an experimental model of endocarditis, the in vivo efficacy of temafloxacin alone and in combination with tobramycin when given at doses which result in concentrations in plasma similar to those obtained in humans and to compare these regimens with penicillin alone and combined with tobramycin. Tobramycin was preferred over another aminoglycoside because its diffusion pattern in vegetations has been described previously (8) and itS in vitro activity is similar to that of gentamicin, which has been studied extensively (2) . Furthermore, as shown in previous experiments (20a) , in combination with penicillin, a once-daily dose of tobramycin is as effective as the same daily dosage administered three times daily (20a) , and so the once-daily regimen was chosen because it is easier to administer. Finally, the distribution pattern of an antibiotic throughout infected cardiac vegetations may represent an important factor conditioning in vivo activity, and because it varies from one compound to another (8, 9) This strain was used to induce endocarditis in rabbits to study both the antibiotic therapy already prescribed to patients (2, 15) and the diffusion of new molecules into large vegetations (8, 9) . The strain was grown at 37°C in a chemically defined medium enriched with 2% Todd-Hewitt dialysate (CDMT) (5) .
In vitro antibiotic susceptibility tests. MICs and MBCs were determined in triplicate by the tube macrodilution method in CDMT containing a lower concentration of cysteine (5 mg/liter; (L-Cys CDMT) to minimize inactivation of penicillin (17) . The inocula were diluted from log-phase cultures to obtain a final concentration of 105 CFU/ml. The antibiotics tested were penicillin G (Specia, Paris, France), tobramycin (Eli Lilly, Saint-Cloud, France), and temafloxacin (Abbott, Rungis, France). The MIC was defined as the lowest concentration of antibiotic that prevented turbidity in the test tube after 24 h of incubation, and the MBC was defined as the lowest concentration of antibiotic that reduced the number of organisms by 99.9% of the original number. MBCs were determined by plating, after 24 h of incubation, 0.1 ml from each clear broth tube onto 5% sheep blood Columbia agar (Bio-Merieux, Marcy l'Etoile, France) enriched with pyridoxal hydrochloride (100 ,ug/ml), and the plates were incubated for 48 h. Tolerance was defined as an MBC/MIC ratio of greater than 32 (20) .
Time-kill curves were plotted with log-phase inocula of 107 CFU/ml in L-Cys CDMT containing penicillin G (20 ,ug/ml), temafloxacin (8 ,g/ml), and tobramycin (18 ,ug/ml) concentrations similar to the peak levels obtained in the sera of treated animals. In addition, temafloxacin was used at a higher concentration (25 ,g/ml) in order to determine a possible concentration effect in vitro. Tobramycin was also tested at the subinhibitory concentration of 2 ,g/ml (1/4 the MIC) in order to visualize a synergistic effect in combination with penicillin G or temafloxacin.
Samples were removed from the tubes after 0, 3, 6, and 24 h and were subjected to 10-fold serial dilutions in sterile saline, with 0.1 ml of each dilution being seeded on enriched agar plates, which were incubated for 48 h. Penicillinase was added to agar for samples containing penicillin. Each experiment was performed twice in duplicate and included controls of growth without antibiotic. In vitro synergy was defined as a 100-fold increase of killing by the combination over that obtained with the single most effective agent and a 1,000-fold decrease of the bacterial count compared with that of the inoculum. The minimal detectable number of CFU per milliliter was 10.
Experimental endocarditis. A modified version of the method of Perlman and Freedman (18) was used to induce endocarditis in female New Zealand White rabbits, each weighing between 2 and 3 kg. As described previously (2), a polyethylene catheter was inserted through the right carotid artery into the left ventricular cavity and was left in place throughout the experiment. Twenty-four hours after placement of the catheter (day 1), animals were inoculated via the marginal ear vein with 10 CFU of strain GaDT in 1 ml of saline. This resulted in endocarditis in 100% of the inoculees, when the catheter was correctly placed, as demonstrated by positive blood cultures on day 7 and by the presence of infected vegetations on the aortic valves at the time of sacrifice. Blood cultures were performed as described previously (2).
Therapeutic studies. ) alone or in combination with either procaine penicillin or temafloxacin. These doses were chosen to obtain concentrations in plasma comparable to those achieved in humans. Another group of rabbits was treated with temafloxacin (100 mg/kg b.i.d., i.m.) in order to assess a potential in vivo dose effect. Each treatment regimen was administered for 4 days. Animals were killed on day 11, 12 h after the last dose of penicillin and temafloxacin or 24 h after the last dose of tobramycin. Untreated control rabbits were sacrificed at the time corresponding to the end of therapy (day 11); one of these animals died on day 8.
At the time of sacrifice, all vegetations were excised, weighed separately, homogenized in 0.5 ml of saline, and quantitatively cultured on pyridoxal-enriched blood agar plates at 37°C for 48 h. The lowest detectable bacterial counts ranged from 2 to 3.5 log1o CFU/g of vegetation,
depending on the size of the vegetation. The vegetation was considered sterile when the culture showed no growth after incubation for 48 h at 37°C, and the number of CFU was recorded as the lowest detectable bacterial count. Drug carryover was avoided by serial dilutions and spreading of the subculture (50 pl) on agar plates or by adding penicillinase to agar for samples containing penicillin.
(ii) Antibiotic levels in serum. Blood was drawn from the ear vein 1 h after the injection of antibiotic on day 10 and at the time of sacrifice for determination of peak and trough concentrations, respectively, and was stored at -70°C.
Penicillin concentrations were measured by agar disk diffusion by using Bacillus subtilis ATCC 6633 as the test strain. Temafloxacin and tobramycin concentrations were measured by high-performance liquid chromatography and a radioenzyme assay, respectively. The lower limits of detection were 0.1 p,g/ml for penicillin, 0.015 ,ug/ml for temafloxacin, and 0.015 ,g/ml for tobramycin; and assay reproducibilities were, ±7, ±5, and ±6%, respectively.
(iii) Statistics. Bacterial densities in vegetations within the experimental groups were compared by an analysis of variance; this was followed by the Scheffe test for multiple comparisons. Results are expressed as means ± standard deviations. The percentage of rabbits with sterile vegetations was compared by the x2 test by using Yates' continuity correction. A Table 1 . Temafloxacin and penicillin levels were greater than the MICs for the infecting strain for the entire therapeutic interval. The peak tobramycin level was fourfold its MIC. In all treated groups, the mean bacterial counts in vegetations were significantly reduced compared with those in control animals (P < 0.001) ( Table 2 ). The mean bacterial counts in vegetations of the temafloxacin, penicillin, and tobramycin single-drug regimen groups were comparable (P > 0.05). The efficacy of a higher dose of temafloxacin (100 mg/kg b.i.d.) was not significantly different from that of the 50-mg/kg dose (3.1 ± 0.8 versus 3.9 ± 0.9 log1O CFU/g). The combination of tobramycin and penicillin significantly reduced the bacterial counts in vegetations compared with the reduction in bacterial counts after treatment with penicillin alone (P < 0.05) but not after that with tobramycin alone. (14), a dose higher than that recommended for treatment of other infections (600 mg). However, in light of the severity of endocarditis, such a high dose can be justified. Most of the rabbits treated with penicillin or temafloxacin alone had infected vegetations at the time of sacrifice. Despite the low penicillin MICs, the response to penicillin therapy varies considerably (4) in NVS endocarditis in humans, and combination therapy with an aminoglycoside is usually recommended for 2 to 4 weeks (1).
The results of the in vitro time-kill studies correlated inconsistently with those of the in vivo experiments. This discordance has been noted previously (2) . Indeed, despite a more rapid killing activity in vitro, temafloxacin alone did not appear to be more effective than penicillin alone in vivo after 4 days of therapy. As shown by our results, this observation cannot be explained by an impaired diffusion into vegetations. A serum effect seems unlikely, since this effect is observed mostly with antibiotics with high levels of serum protein binding. No serum effect was seen with temafloxacin on Staphylococcus aureus (22) . Moreover, this effect is usually circumvented by increasing the dose in order to increase the percentage of free antibiotic in the serum. In this study, the in vitro killing rate of temafloxacin was not markedly affected by a tripling of its concentration. An increase in the temafloxacin dose from 50 to 100 mg/kg in vivo did not modify the therapeutic results after 4 days of therapy. With this latter dose, which is clinically unrealistic, we observed high trough concentrations, suggesting a cumulative effect. The discrepancy between the results of in vitro and in vivo experiments might be related to differences in the growth conditions of these fastidious organisms. The medium used in the present study, CDMT, has been shown to be suitable for balanced growth, but it does not simulate the growth conditions in vegetations. Frehel et al. (11) have shown that, in the vegetation, the ultrastructure of the organism is modified and that the observed modifications suggested impaired growth conditions. The influence of the growth rate on the susceptibilities of these streptococci to fluoroquinolones as well as the presence in vivo of an exopolysaccharide coat on the organisms in the vegetations (11) remains to be clarified, but it could account for the differences noted between in vitro and in vivo temafloxacin activities.
The activities of tobramycin in vitro and in vivo were similar to those of temafloxacin. Peak and trough tobramycin levels in serum were the same as those obtained with a once-daily aminoglycoside dosage in humans, which is often recommended (12) . Although aminoglycosides alone are not recommended for treatment of streptococcal endocarditis, gentamicin has been shown to exhibit in vivo activity against enterococci, even though resistance has been observed in vitro, as measured by conventional assays to determine MICs and MBCs (16 and 32 ,ug/ml, respectively, for the Streptococcus faecalis strain tested) (21).
The combination of tobramycin and penicillin significantly enhanced the efficacy of penicillin alone. This result is in agreement with those of Carey et al. (6) and our previous study (2) , which demonstrated an in vivo synergism between penicillin and other aminoglycosides. The addition of tobramycin to temafloxacin also decreased the log1o CFU per gram of vegetation compared with that of temafloxacin alone, although the difference was not significant. Nevertheless, considering the number of rabbits with sterile vegetations, the combination groups were significantly more effective than the single-drug regimens, except for temafloxacin-tobramycin compared with tobramycin alone. The combination of temafloxacin and tobramycin was as effective as penicillin plus tobramycin, which was taken as the reference regimen for NVS endocarditis in this study, and six of seven rabbits had sterile vegetations at the end of treatment. This result is in agreement with time-kill curves.
In the present study, we showed that ['4C]temafloxacin penetrated into and homogeneously diffused throughout the VOL. 36, 1992 vegetations. Although it seems logical to hypothesize that, to sterilize a vegetation, the antibiotic should be able to diffuse throughout the infective lesion, the predictive value of the autoradiographic diffusion pattern of antibiotics into vegetation for therapeutic efficacy is still not known. The concentration gradient between the periphery and the core of the vegetation observed with ["4C]ceftriaxone (9) and, to a lesser degree, with ["4C]penicillin (8) 
